Avistone Pharmaceuticals
PrivateLast Round
Series B
Jan 4, 2024
Total Funding Raised
$340M
Company Overview
Avistone Pharmaceuticals is a biotechnology company that develops innovative drugs for tumor treatment and precision oncology therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avistone Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Avistone Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2024 | ||||
| Series A | Dec 8, 2021 |
Avistone Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B |
| Yanchuang Capital | Series B |
| IDG Capital | Series B |
| Bain Capital, LP | Series A, Series B |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Presented results at the ASCO Annual Meeting 2025.
- Jun 1, 2025
Encouraging results for combination therapy in lung cancer presented at ASCO.
Avistone Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avistone Pharmaceuticals's valuation, stock price, and market status.
